JOURNAL OF PEDIATRIC SURGERY, vol.54, no.7, pp.1384-1390, 2019 (SCI-Expanded)
Background/purpose: This multicenter, randomized, partially-blinded phase IIb study evaluated the pharmacokinetics (PK)/pharmacodynamics, safety, and tolerability of aprepitant in pediatric subjects for the prevention of postoperative nausea and vomiting (PONV).